Core Cap Advisors, LLC Incyte Corp Transaction History

Core Cap Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$67.18 - $84.11 $194,015 - $242,909	2,888 New	2,888 $231,000
Q2 2022 Aug 11, 2022	BUY	$66.18 - $83.18 $1.32 Million - $1.66 Million	19,997 New	19,997 $1.52 Million
Q1 2022 Apr 29, 2022	SELL	$66.02 - $79.71 $3,301 - $3,985	-50 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$63.34 - $74.11 $3,167 - $3,705	50 New	50 $4,000

657

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Core Cap Advisors, LLC with notifications on news.